Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Hers vs Vea Health

Hers
Graded #252

Higher grade

vs+8.899999999999999
Vea Health
Graded #451

Lower grade

The verdict

Hers takes it — 63.9/100 to 55/100.

Hers grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Women-focused telehealth brand from Hims and Hers offering compounded semaglutide on a 6-month plan.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHers +9
54
45
Dose & formulationHers +26
77
51
Clinical oversightHers +5
71
66
Labs & monitoringEven
52
52
FulfillmentHers +13
81
68
Contract termsVea Health +14
41
55
Hers · left barVea Health · right bar

The numbers

MetricHersVea Health
WeighScore63.9/10055/100
GradeCC
Scorecard rank#252#451
Semaglutide$199/mo (starting dose, compounded)Not disclosed
Tirzepatide$299/mo (starting dose, plus a separate fee, brand-name)Not disclosed
CoverageAll 50 statesAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
Hers

Graded #252 · C

Strengths

  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
Vea Health

Graded #451 · C

Strengths

  • Publishes the FDA compounded-medication disclaimer
  • Oral and injection protocols for both semaglutide and tirzepatide
  • Claims 50-state coverage via a clinician network
  • Clearly differentiated positioning (longevity, men's health, performance)

Where it loses points

  • Pricing not shown until after sign-up
  • Pharmacy partner not named (only 'U.S.-based pharmacy')
  • LegitScript certification status not visible
  • No named medical director
  • 503A vs 503B designation not specified

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard